TAKEDA PHARM.CO.LTD./ JP3463000004 /
8/30/2024 9:55:17 PM | Chg. +0.010 | Volume | Bid10:01:22 PM | Ask10:01:22 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
26.990EUR | +0.04% | 141 Turnover: 3,798.970 |
26.920Bid Size: 130 | 27.220Ask Size: 130 | 42.15 bill.EUR | - | - |
Assets
2016 - in mill. JPY |
2017 - in mill. JPY |
2018 - in mill. JPY |
2019 - in mill. JPY |
2020 IFRS in mill. JPY |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 551,916 | 527,344 | 536,801 | 1.32 mill. | 1.39 mill. | ||||||
Intangible Assets | 743,128 | 1.07 mill. | 1.01 mill. | 4.86 mill. | 4.17 mill. | ||||||
Long-Term Investments | 149,548 | 126,411 | 107,949 | 114,658 | 262,121 | ||||||
Fixed Assets | - | - | - | - | - | ||||||
Inventories | 254,010 | 226,048 | 212,944 | 986,744 | 759,599 | ||||||
Accounts Receivable | 415,379 | 423,405 | 420,247 | 741,907 | 757,005 | ||||||
Cash and Cash Equivalents | 451,426 | 319,455 | 294,522 | 702,093 | 637,614 | ||||||
Current Assets | 1.37 mill. | 1.26 mill. | 1.08 mill. | 3.05 mill. | 2.47 mill. | ||||||
Total Assets | 3.82 mill. | 4.35 mill. | 4.11 mill. | 13.87 mill. | 12.82 mill. |
Liabilities
2016 - in mill. JPY |
2017 - in mill. JPY |
2018 - in mill. JPY |
2019 - in mill. JPY |
2020 IFRS in mill. JPY |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 191,089 | 240,623 | 240,259 | 327,394 | 318,816 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | 265,632 | 545,028 | 18 | 984,946 | 586,817 | ||||||
Provisions | 201,023 | 270,213 | 186,461 | 1.02 mill. | 930,490 | ||||||
Liabilities | 1.81 mill. | 2.41 mill. | 2.09 mill. | 8.71 mill. | 8.09 mill. | ||||||
Share Capital | 64,766 | 65,203 | 77,914 | 1.64 mill. | 1.67 mill. | ||||||
Total Equity | 2.01 mill. | 1.95 mill. | 2.02 mill. | 5.16 mill. | 4.73 mill. | ||||||
Minority Interests | 62,511 | 54,704 | 19,985 | 4,006 | 4,003 | ||||||
Total liabilities equity | 3.82 mill. | 4.35 mill. | 4.11 mill. | 13.87 mill. | 12.82 mill. |
Income Statement
2016 - in mill. JPY |
2017 - in mill. JPY |
2018 - in mill. JPY |
2019 - in mill. JPY |
2020 IFRS in mill. JPY |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.81 mill. | 1.73 mill. | 1.77 mill. | 2.1 mill. | 3.29 mill. | ||||||
Depreciation (total) | 125,140 | 156,717 | 122,131 | 203,372 | 455,420 | ||||||
Operating Result | 130,828 | 155,867 | 241,789 | 204,969 | 100,408 | ||||||
Interest Income | -10,286 | -10,976 | 7,615 | -66,446 | -137,175 | ||||||
Income Before Taxes | 120,539 | 143,346 | 217,205 | 94,896 | -60,754 | ||||||
Income Taxes | 37,059 | 27,833 | 30,497 | -14,118 | -105,044 | ||||||
Minority Interests Profit | -3,313 | -573 | 178 | 112 | -49 | ||||||
Net Income | 80,166 | 114,940 | 186,886 | 109,126 | 44,241 |
Per Share
Cash Flow
2016 - in mill. JPY |
2017 - in mill. JPY |
2018 - in mill. JPY |
2019 - in mill. JPY |
2020 IFRS in mill. JPY |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 25,491 | 261,363 | 377,854 | 328,479 | 669,752 | ||||||
Cash Flow from Investing Activities | -71,208 | -655,691 | -93,342 | -2.84 mill. | 292,119 | ||||||
Cash Flow from Financing | -124,839 | 289,896 | -326,226 | 2.95 mill. | -1.01 mill. | ||||||
Decrease / Increase in Cash | -170,557 | -104,432 | -41,714 | 439,018 | -43,342 | ||||||
Employees | 31,168 | - | 27,230 | 49,578 | 47,495 |